| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |